|
1
|
Oye KA, Eichler HG, Hoos A, Mori Y, Mullin TM, Pearson M. Pharmaceuticals Licensing and Reimbursement in the European Union, United States, and Japan. Clin Pharmacol Ther 2016; 100:626-632. [DOI: 10.1002/cpt.505] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2016] [Revised: 08/22/2016] [Accepted: 08/28/2016] [Indexed: 12/26/2022]
Affiliation(s)
- KA Oye
- Massachusetts Institute of Technology; Cambridge Massachusetts USA
| | | | | | - Y Mori
- Ministry of Education, Culture, Sports, Science and Technology (MEXT); Tokyo Japan
| | - TM Mullin
- U.S. Food and Drug Administration; Silver Spring Maryland USA
| | - M Pearson
- Organization for Economic Cooperation and Development; Paris France
| |
Collapse
|
|
2
|
Oye KA, Jain G, Amador M, Arnaout R, Brown JS, Crown W, Ferguson J, Pezalla E, Rassen JA, Selker HP, Trusheim M, Hirsch G. The next frontier: Fostering innovation by improving health data access and utilization. Clin Pharmacol Ther 2015; 98:514-21. [PMID: 26234275 PMCID: PMC5052021 DOI: 10.1002/cpt.191] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2015] [Revised: 07/24/2015] [Accepted: 07/26/2015] [Indexed: 12/24/2022]
Affiliation(s)
- K A Oye
- Massachusetts Institute of Technology (MIT) Department of Political Science and Engineering Systems Division, Cambridge, Massachusetts, USA
| | - G Jain
- Center for Biomedical Innovation, MIT, Cambridge, Massachusetts, USA
| | - M Amador
- MIT Portugal Program, International Risk Governance Council Portugal, Portugal
| | - R Arnaout
- Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.,Department of Pathology, Harvard Medical School (HMS), Boston, Massachusetts, USA
| | - J S Brown
- Department of Population Medicine, Harvard Pilgrim Health Care Institute and HMS, Boston, Massachusetts, USA
| | - W Crown
- Optum Labs, Boston, Massachusetts, USA
| | | | - E Pezalla
- Aetna, Inc., Hartford, Connecticut, USA
| | | | - H P Selker
- Tufts Clinical and Translational Science Institute, Tufts University, and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, USA
| | - M Trusheim
- Sloan School of Management, MIT, Cambridge, Massachusetts, USA
| | - G Hirsch
- Center for Biomedical Innovation, MIT, Cambridge, Massachusetts, USA
| |
Collapse
|
|
4
|
Oye KA. The precautionary principle and international conflict over domestic regulation: mitigating uncertainty and improving adaptive capacity. Water Sci Technol 2005; 52:59-64. [PMID: 16304935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
Disputes over invocation of precaution in the presence of uncertainty are building. This essay finds: (1) analysis of past WTO panel decisions and current EU-US regulatory conflicts suggests that appeals to scientific risk assessment will not resolve emerging conflicts; (2) Bayesian updating strategies, with commitments to modify policies as information emerges, may ameliorate conflicts over precaution in environmental and security affairs.
Collapse
Affiliation(s)
- K A Oye
- Center for International Studies, Massachusetts Institute of Technology, Cambridge 02139, USA.
| |
Collapse
|